Pacira Pharmaceuticals (PCRX) PT Raised to $32 at Needham
Tweet Send to a Friend
(Updated - February 28, 2025 8:03 AM EST)
Needham analyst Serge Belanger raised the price target on Pacira Pharmaceuticals ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Needham analyst Serge Belanger raised the price target on Pacira Pharmaceuticals ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
